Evidence-Based Acupuncture for Neuropathy

CONTINUING EDUCATION CREDITS:
8 CEU/PDA/CPD accepted by CA #383 (Category 1), NCCAOM (6 AOM-AC, 2 AOM-BIO), FL (5 Biomed, 3 General), IL, TX (Biomedicine), AHPRA, AFPA, BAcC, CTCMA, NZASA, NZRA

COURSE TYPE:
Distance Learning CEU Video (Online)

COURSE DESCRIPTION:
This course provides an introduction to evidence-based practice and a general overview of neuropathy. It outlines the important biological factors of etiology in the various types of neuropathies and develops an evidence-based practice model through the review of current and historically significant research on acupuncture and neuropathy. The course then introduces an evidence-based treatment template and applies it through case study analysis. By the end of the course, participants should be confident in having a strong evidence-based approach to treating neuropathy with acupuncture. This includes the ability to discuss the biomedical effects of acupuncture treatment with specific details about the relevant biomarkers of neuropathy and how to use this information in patient education.

Learning Objectives:

• Define evidence-based medicine and explain its importance for acupuncture treatments.
• Identify the various types of neuropathies and the basic diagnostic criteria for neuropathy according to current medical standards.
• Understand the biological factors in the etiology of the various types of neuropathies according to current biomedical standards.
• Explain the basic biological mechanisms of action by which acupuncture can help alleviate neuropathic symptoms.
• Formulate an evidence-based treatment protocol using data from peer-reviewed research articles.
• Communicate effectively with patients and conventional medical practitioners using biomedical language.
• Apply what you have learned to educate your patients and market your acupuncture service.

CANCELLATION POLICY:
These online courses are immediately accessible after purchase therefore are non-refundable.

For more info on Online Videos, click here to visit our FAQ page.